| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/20/2001 | CA2401252A1 Human and humanized fap-alpha-specific antibodies |
| 09/20/2001 | CA2400825A1 Three-dimensional model of a fc region of an ige antibody and uses thereof |
| 09/20/2001 | CA2400238A1 Human nim1 kinase |
| 09/20/2001 | CA2400106A1 Antibodies to human cd154 |
| 09/20/2001 | CA2374155A1 A detection method of protein-protein interaction |
| 09/20/2001 | CA2374069A1 Phosphorus-controllable recombinant expression of polypeptides in plants |
| 09/20/2001 | CA2373414A1 A novel factor-h related protein 5 and antobodies thereto |
| 09/20/2001 | CA2373110A1 Production of chimeric capsid vectors |
| 09/19/2001 | EP1134687A2 Method for displaying results of hybridization experiments |
| 09/19/2001 | EP1134293A2 Comparative genomic hybridization (CGH) |
| 09/19/2001 | EP1134287A1 A system to control the expression of a given gene using another gene that encodes a polypeptide with recombinant activity |
| 09/19/2001 | EP1134286A2 Adamts polypeptides, nucleic acids encoding them, and uses thereof |
| 09/19/2001 | EP1134285A1 Nucleic acid fragment, recombinant vector containing the same and method of promoting the expression of structural gene by using the same |
| 09/19/2001 | EP1134284A1 Creatine amidinohydrolase and process for producing the same |
| 09/19/2001 | EP1134230A1 Novel polypeptide |
| 09/19/2001 | EP1133997A2 Treatment of immune diseases with beta-interferon |
| 09/19/2001 | EP1133995A2 Interleukin-1 inhibitors |
| 09/19/2001 | EP1133994A1 A method for reversing the immunosuppressive effects of the Melanoma Inhibitory Activity "MIA" |
| 09/19/2001 | EP1133988A1 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene |
| 09/19/2001 | EP1133698A1 Prion protein standard and method of making same |
| 09/19/2001 | EP1133695A1 Immunostimulatory dna |
| 09/19/2001 | EP1133689A1 Method for diagnosing neoplasia |
| 09/19/2001 | EP1133575A2 Methods and compositions for diagnosis and treatment of cancer based on the transcription factor ets2 |
| 09/19/2001 | EP1133574A1 Methods and apparatus for flow-through hybridization |
| 09/19/2001 | EP1133572A2 Chlamydia pneumoniae genome sequence |
| 09/19/2001 | EP1133570A1 Organisms for the extracellular production of riboflavin |
| 09/19/2001 | EP1133569A1 Hiv vaccine |
| 09/19/2001 | EP1133568A2 Regulatory sequences useful for gene expression in plant embryo tissue |
| 09/19/2001 | EP1133566A1 Dna encoding fusion proteins which are specifically cleavable by copper (ii) ions |
| 09/19/2001 | EP1133565A2 Generation of specific binding partners binding to (poly)peptides encoded by genomic dna fragments or ests |
| 09/19/2001 | EP1133564A1 Zace1: a human metalloenzyme |
| 09/19/2001 | EP1133563A2 Methods and molecules relating to cd39-like polypeptides |
| 09/19/2001 | EP1133562A1 The gene cluster involved in aclacinomycin biosynthesis, and its use for genetic engineering |
| 09/19/2001 | EP1133561A2 Protein fragments for use in protein targeting |
| 09/19/2001 | EP1133560A1 Human parathyroid hormone modifications, preparation and use |
| 09/19/2001 | EP1133559A2 Human orphan g protein-coupled receptors |
| 09/19/2001 | EP1133558A1 Compositions and methods for increasing bone mineralization |
| 09/19/2001 | EP1133557A2 Growth factor modulators |
| 09/19/2001 | EP1133556A1 Root-preferred promoters and their use |
| 09/19/2001 | EP1133554A2 Polypeptides having choline oxidase activity and nucleic acids encoding same |
| 09/19/2001 | EP1133553A1 Methods using genetic package display for detecting and identifying protein-protein interactions |
| 09/19/2001 | EP1133552A2 Methods and reagents for increasing proliferative capacity and preventing replicative senescence |
| 09/19/2001 | EP1133523A1 Generation of antibodies using polynucleotide vaccination in avian species |
| 09/19/2001 | EP1133520A2 Compositions and methods using lactadherin or variants thereof |
| 09/19/2001 | EP1133519A2 Functional antagonists of hedgehog activity |
| 09/19/2001 | EP1133517A1 INTRACELLULAR TARGETED DELIVERY OF COMPOUNDS BY 70 kD HEAT SHOCK PROTEIN |
| 09/19/2001 | EP1133516A1 Chromosome 17p-linked prostate cancer susceptibility gene |
| 09/19/2001 | EP1133515A1 Dna molecules encoding hg51, a g-protein-coupled receptor |
| 09/19/2001 | EP1133514A1 Method for the electrochemical detection of nucleic acid oligomer hybrids |
| 09/19/2001 | EP1133513A1 Multidomain polynucleotide molecular sensors |
| 09/19/2001 | EP1133465A1 Amphiphilic polyamine compounds |
| 09/19/2001 | EP1133359A1 Ultrathin-walled multiwell plate for heat block thermocycling |
| 09/19/2001 | EP1133310A2 Artery- and vein-specific proteins and uses therefor |
| 09/19/2001 | EP1133294A1 Compositions and methods for the treatment of alzheimer's disease, central nervous system injury, and inflammatory diseases |
| 09/19/2001 | EP1092041A4 Exonuclease-mediated nucleic acid reassembly in directed evolution |
| 09/19/2001 | EP0981609B1 A method to clone mrnas and display of differentially expressed transcripts (dodet) |
| 09/19/2001 | EP0948522A4 Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines |
| 09/19/2001 | EP0876509B1 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 09/19/2001 | EP0876095A4 Electroporation-mediated molecular transfer in intact plants |
| 09/19/2001 | EP0874897A4 Production of water stress or salt stress tolerant transgenic cereal plants |
| 09/19/2001 | EP0862634B1 Pharmaceutical composition for treating papillomavirus tumours and infection |
| 09/19/2001 | EP0754751B1 Novel deoxyribonuclease |
| 09/19/2001 | EP0612244B1 Endothelin receptor antagonists |
| 09/19/2001 | EP0603406B1 Fowl mycoplasma antigen, gene thereof, recombinant vector containing said gene, and vaccine prepared by utilizing the same |
| 09/19/2001 | EP0593755B1 Defective recombinant adenoviruses expressing cytokines for use in antitumoral treatment |
| 09/19/2001 | EP0591369B1 Capsid forming and cystein modified chimaeric ms2-coat protein |
| 09/19/2001 | CN1313908A Assays using crosslinkable immobilized nucleic acids |
| 09/19/2001 | CN1313907A Process for preparing peptide nucleic acid probe using polymeric photoacid generator |
| 09/19/2001 | CN1313906A Single nucleotide polymorphic discrimination by electronic dot blot assay on semiconductor microchips |
| 09/19/2001 | CN1313904A Reduction of Bowman-Birk Protease inhihitor levels in plants |
| 09/19/2001 | CN1313903A Compound and method for the prevention and/or the treatment of allergy |
| 09/19/2001 | CN1313902A DNA constructs comprising protease encoding sequences or inhitors thereof |
| 09/19/2001 | CN1313901A Novel human lysozyme gene, its encoding polypeptide and the method for preparing them |
| 09/19/2001 | CN1313900A Novel human lysozyme gene, its encoding polypeptide and the method preparing for them |
| 09/19/2001 | CN1313899A Novel human lysozyme gene, its encoding polypeptide and the method for preparing them |
| 09/19/2001 | CN1313898A Overexpression of phytase genes in yeast systems |
| 09/19/2001 | CN1313897A New gene of humanlysoenzyme, the encoding polypeptide and methods for preparing them |
| 09/19/2001 | CN1313896A Method for producing a peptide with a PI above 8 or below 5 |
| 09/19/2001 | CN1313894A MAP kinase phosphatase mutant |
| 09/19/2001 | CN1313893A FY7 polymerase |
| 09/19/2001 | CN1313891A Methods of monitoring disease states and therapies using gene expression profiles |
| 09/19/2001 | CN1313873A Polyester analogus of poly-L-Lysine as a soluble, biodegradable gene delivery carrier |
| 09/19/2001 | CN1313865A Saccharide transporter |
| 09/19/2001 | CN1313864A Particles of HCV envelope proteins use of vaccination |
| 09/19/2001 | CN1313775A Methods and materials for the treatment of prostatic cercinoma |
| 09/19/2001 | CN1313773A Antigenic peptides derived from telomerase |
| 09/19/2001 | CN1313772A Peptide antagonists of zonulin and methods for use of same |
| 09/19/2001 | CN1313401A Polypeptide-human space I enzyme 11 and polynucleotide for coding it |
| 09/19/2001 | CN1313400A Polypeptide-human ATP-dependent serine protein hydrolase 13 and polynucleotide for coding it |
| 09/19/2001 | CN1313399A Polypeptide-human signalase 15 and polynucleotide for coding it |
| 09/19/2001 | CN1313398A Polypeptide-human vacuolus proton-acylaglycon triphosphatase C subunit 22 and polynucleotide for coding it |
| 09/19/2001 | CN1313396A Polypeptide-human transglutaminase 12 and polynucleotide for coding it |
| 09/19/2001 | CN1313394A Polypeptide-DNA polymerase 10 and polynucleotide for coding it |
| 09/19/2001 | CN1313393A Polypeptide-human RNA unwindase 13 and polynucleotide for coding it |
| 09/19/2001 | CN1313392A 番茄植酸酶基因 Tomato phytase gene |
| 09/19/2001 | CN1313391A Polypeptide-human hexokinase protein 10 and polynucleotide for coding it |
| 09/19/2001 | CN1313387A Method for expression various proteins in plants with converted genes |
| 09/19/2001 | CN1313386A Kuhseng agglutinin and its zoophobous and disease-resistant coding gene and application |
| 09/19/2001 | CN1313385A Process for preparing genetically engineered efficient medicine target-introduced to human liver cells |
| 09/19/2001 | CN1313342A Human testis lactate dehydrogenase A gene coded protein |